Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Tuberculosis treatment Stories

2011-10-27 01:00:00

LILLE, France, Oct. 27, 2011 /PRNewswire/ -- The Eli Lilly and Company Foundation has committed US $30 million in funding to further support The Lilly MDR-TB Partnership in its fight against multidrug-resistant tuberculosis - a disease that disproportionately affects developing countries and kills more than 150,000 people each year. The announcement was made ahead of the opening of the 42nd Union World Conference on Lung Health in Lille, France, later this week. Eli Lilly and Company...

2011-10-20 13:44:04

Cambodian study demonstrates that starting antiretroviral treatment two weeks, not two months, after TB treatment increases survival 33 percent Timing is everything when treating patients with both HIV and tuberculosis. Starting HIV therapy in such patients within two weeks of TB treatment, rather than two months as is the current practice, increases survival by 33 percent, according to a large-scale clinical trial in Cambodia led by researchers at Children's Hospital Boston and the Immune...

2011-10-20 12:47:19

New study finds that optimal time to integrate HIV treatment with TB therapy may depend on the degree to which the patient's immune system is compromised In sub-Saharan Africa, tuberculosis is the disease that most often brings people with HIV into the clinic for treatment. Infection with both diseases is so common that in South Africa, for instance, 70% of tuberculosis patients are HIV positive. How best to treat these doubly infected patients-- who number around 700,000 globally-- is the...

2011-10-19 16:00:00

Cambodian study demonstrates that starting antiretroviral treatment two weeks, not two months, after TB treatment increases survival 33 percent BOSTON, Oct. 19, 2011 /PRNewswire-USNewswire/ -- Timing is everything when treating patients with both HIV and tuberculosis. Starting HIV therapy in such patients within two weeks of TB treatment, rather than two months as is the current practice, increases survival by 33 percent, according to a large-scale clinical trial in Cambodia led by...

TB Cases Globally Decline For First Time
2011-10-11 11:23:30

The World Health Organization (WHO) said on Tuesday that the number of people getting sick with tuberculosis declined last year for the first time. The United Nations health agency said 8.8 million people fell ill with TB in 2010, and 1.4 million died. The WHO said that 1.8 million people in 2004 died from TB, and 9 million became sick from it in 2005. "This is major progress. But it is no cause for complacency." U.N. Secretary-General Ban Ki-moon said in a statement. "Too many...

2011-10-03 12:00:53

Findings point to need for interventions to help patients take drugs properly Patients being treated for chronic hepatitis C become less likely to take their medications over time, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Since the study also showed better response to the drugs when they're taken correctly, the researchers say the findings should prompt clinicians to assess patients for barriers to medication adherence throughout...

2011-09-19 23:50:33

A regulatory bias against taking oral anti-cancer medications with food places many patients at increased risk for an overdose and forces them to "flush costly medicines down the toilet," argues Mark Ratain, MD, an authority on cancer-drug dosing. In a commentary published early online Sept. 19 in the Journal of Clinical Oncology, Ratain, the Leon O. Jacobson professor of medicine and director of the Center for Personalized Therapeutics at the University of Chicago Medical Center, says it...

2011-08-23 20:03:34

Afghan patients treated at a U.S. military hospital in Afghanistan often carry multidrug-resistant (MDR) bacteria, according to a report in the September issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. The findings underscore the need for effective infection control measures at deployed hospitals where both soldiers and local patients are treated, the study's authors say. The research team, led by Air Force Lieutenant...

2011-08-17 12:19:16

Published in Journal of Applied Microbiology Researchers have discovered a faster, cheaper method for the diagnosis of tuberculosis (TB). A major barrier in TB prevention, especially in developing countries, is that diagnosis is slow and costly. Dr Olivier Braissant and his colleagues have developed a method which could potentially decrease the time taken to make a diagnosis. Their method is also cheaper than the current fastest methods. This research has been published today in the Society...

2011-08-11 21:45:22

Pyrazinamide has been used in combination with other drugs as a first-line treatment for people with tuberculosis (TB) since the 1950s, but exactly how the drug works has not been well understood. Now, researchers have discovered a key reason why the drug effectively shortens the required duration of TB therapy. The finding potentially paves the way for the development of new drugs that can help eliminate TB in an infected individual even more rapidly. The study was supported by the National...